Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Heart Failure
Clinical trial register · Netherlands

Heart Failure Trials in Netherlands, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Netherlands and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3171 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:17 UTC
3171
Studies in scope
all four open statuses
1789
Recruiting now
open to new participants
601
Lead sponsors
across recruiting studies
Top sites
Groningen 14 Rotterdam 12 Amsterdam 11 Nieuwegein 10 Eindhoven 8
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University Medical Center Groningen5 Medisch Spectrum Twente3 Boehringer Ingelheim2 Novo Nordisk A/S2 VDI Technologies1 XVIVO Perfusion1 Zuyderland Medisch Centrum1 Corvia Medical1 Radboud University Medical Center1 Noah Labs1 EBR Systems, Inc.1 Medtronic1 Boston Scientific Corporation1 Abbott Medical Devices1 Zoll Medical Corporation1 Ancora Heart, Inc.1 Merck Sharp & Dohme LLC1 UMC Utrecht1 V-Wave Ltd1 Erasmus Medical Center1 Franciscus Gasthuis1 Netherlands Heart Institute1 Foundry Innovation & Research 1, Limited (FIRE1)1 Universitat Internacional de Catalunya1 AstraZeneca1 University Hospital, Geneva1 MicroPort CRM1 St. Antonius Hospital1 Maastricht University Medical Center1 Eli Lilly and Company1 srdpiers1
Site location
Groningen14 Rotterdam12 Amsterdam11 Nieuwegein10 Eindhoven8 Maastricht8 Enschede6 Utrecht5 Breda5 Zwolle4 's-Hertogenbosch4 Heerlen3 Nijmegen3 Almelo2 Leiden2 Deventer2 Ede2 Gouda2 Leeuwarden2 Assen1 Almere Stad1 Apeldoorn1 Roermond1 Sittard1 Alkmaar1 Emmen1 Born1 Haarlem1 Beverwijk1 Dirksland1 Venlo1 Arnhem1 Leiderdorp1
All 33 locations
Target enrolment
to

Heart Failure trials in Netherlands

39 of 3171 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Netherlands
Start
Not yet open
Medisch Spectrum Twente
Phase 4
258
Enschede
2027-01
Active, closed
Medisch Spectrum Twente
Not applicable
1,320
Eindhoven, Amsterdam, Enschede, Rotterdam, Nieuwegein
2026-10-09
Not yet open
Zoll Medical Corporation
Not applicable
800
Groningen
2026-10-01
Recruiting
A Study of LY3971297 in Participants With Heart Failure
NCT07547540Heart Failure, Heart Failure, Diastolic, Heart Failure, Systolic
Eli Lilly and Company
Phase 1
90
Groningen
2026-08-11
By invitation
Medisch Spectrum Twente
Observational
95
Enschede
2026-07-13
Not yet open
University Medical Center Groningen
Not applicable
292
Groningen, 's-Hertogenbosch, Leeuwarden, Maastricht, Nieuwegein
2026-07
Recruiting
University Medical Center Groningen
Phase 2
100
Groningen
2026-05-12
Recruiting
Novo Nordisk A/S
Phase 3
5,610
's-Hertogenbosch, Amsterdam, Beverwijk, Breda, Dirksland, Ede, Eindhoven, Gouda
2026-05-11
Recruiting
Netherlands Heart Institute
Phase 3
1,100
Alkmaar, Amsterdam, Breda, Eindhoven, Emmen, Groningen, Nieuwegein
2026-05-04
Not yet open
Effectiveness and Safety of Uptitration of Guideline Directed MEdical Therapy in Heart Failure With Reduced Ejection Fraction With Limited Kidney Function Assessments
NCT07275437Heart Failure, Heart Failure and Reduced Ejection Fraction, Heart Failure and Mildly Reduced Ejection Fraction
University Medical Center Groningen
Not applicable
344
Amsterdam, Leeuwarden
2026-04-01
Not yet open
Universitat Internacional de Catalunya
Observational
90
Maastricht
2026-03
Not yet open
RAPIDE: The Feasibility of a Hybrid Care Model
NCT06735404Diabetes Type 2, Heart Failure
Radboud University Medical Center
Not applicable
180
Nijmegen
2026-01
Recruiting
Novo Nordisk A/S
Phase 2
200
Amsterdam, Heerlen, Nijmegen, Rotterdam, Venlo
2025-06-30
Recruiting
Boehringer Ingelheim
Phase 3
4,200
Groningen, Maastricht, Nieuwegein, Zwolle
2025-05-20
Recruiting
VDI Technologies
Observational
360
Eindhoven
2025-03-18
Recruiting
AstraZeneca
Phase 3
11,300
's-Hertogenbosch, Almelo, Amsterdam, Born, Deventer, Ede, Enschede, Haarlem
2025-03-14
Active, closed
Pre-Symptomatic Detection of Impending Decompensation in Heart Failure Through Voice Data
NCT07443969Heart Failure, Chronic Heart Failure, Chronic Heart Disease
Noah Labs
Observational
123
Heerlen, Maastricht
2025-01-09
Recruiting
OBESE-HFpEF: Towards Preventing Obesity Related HFpEF
NCT07539766Heart Failure and Preserved Ejection Fraction, Obesity (Disorder), Heart Failure
Zuyderland Medisch Centrum
Observational
250
Heerlen
2025-01-01
Recruiting
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
NCT06526195Heart Failure, Heart Diseases, Cardiovascular Diseases, Pulmonary Hypertension
Abbott Medical Devices
Not applicable
850
Rotterdam, Utrecht
2024-12-13
Recruiting
University Hospital, Geneva
Not applicable
220
Maastricht
2024-10-01
Recruiting
Left Bundle Branch Area Pacing or Biventricular Pacing in AF and Left Ventricular Dysfunction
NCT06620705Heart Failure, Block, Heart, Pacing-Induced Cardiomyopathy
srdpiers
Not applicable
34
Leiden
2024-09-10
Active, closed
XVIVO Perfusion
Not applicable
40
Groningen, Rotterdam, Utrecht
2024-08-03
Recruiting
Boehringer Ingelheim
Phase 3
6,712
's-Hertogenbosch, Arnhem, Breda, Deventer, Eindhoven, Gouda, Leiderdorp, Nieuwegein
2024-06-17
Active, closed
Franciscus Gasthuis
Not applicable
420
Rotterdam
2024-02-26
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
342
Rotterdam, Groningen, Utrecht
2023-05-31
Recruiting
St. Antonius Hospital
Observational
6,000
Amsterdam, Eindhoven, Enschede, Groningen, Nieuwegein, Nijmegen, Rotterdam
2023-05-01
Active, closed
RESPONDER-HF Trial
NCT05425459Heart Failure, Heart Failure, Diastolic
Corvia Medical
Not applicable
750
Groningen
2022-11-17
Active, closed
University Medical Center Groningen
Phase 3
1,750
Assen, Almere Stad, Apeldoorn, Roermond, Sittard, Breda, Amsterdam, Almelo
2022-11-08
Recruiting
Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal Study
NCT05851053Neoplasm, Breast, Heart Failure, Cardiotoxicity, Ventricular Dysfunction
University Medical Center Groningen
Observational
455
Groningen
2022-09-01
Active, closed
Erasmus Medical Center
Observational
4,289
Rotterdam
2022-06-05
Recruiting
The Multicenter Cardiology Monitoring Platform Registry
NCT04976348Heart Failure, Cardiomyopathies, Atrial Fibrillation, Ventricular Arrythmia
Maastricht University Medical Center
Observational
40,000
Maastricht
2021-07-01
Active, closed
Image Supported Lead Placement in CRT
NCT05053568Heart Failure
UMC Utrecht
Not applicable
130
Rotterdam, Amsterdam, Groningen, Maastricht, Nieuwegein, Utrecht, Zwolle
2021-02-08
Active, closed
Assessment of the Axone Micro Quadripolar Lead for Enhanced Cardiac Resynchronization Therapy
NCT04463641Heart Failure, Cardiac Resynchronization Therapy
MicroPort CRM
Not applicable
92
Zwolle
2020-12-03
Active, closed
Foundry Innovation & Research 1, Limited (FIRE1)
Not applicable
50
Rotterdam, Groningen
2019-11-22
Active, closed
Ancora Heart, Inc.
Not applicable
132
Nieuwegein, Rotterdam
2019-01-15
Active, closed
V-Wave Ltd
Not applicable
605
Nieuwegein, Amsterdam, Rotterdam
2018-09-19
Active, closed
EBR Systems, Inc.
Not applicable
300
Zwolle
2018-01-17
Active, closed
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
NCT01385176Heart Failure, Congestive Heart Failure
Boston Scientific Corporation
Not applicable
118
Eindhoven, Utrecht
2011-09-21
Recruiting
Medtronic
Observational
20,000
Amsterdam, Breda, Eindhoven, Enschede, Groningen, Leiden, Maastricht, Nieuwegein
1983-01
Rows per page Showing 1–39 of 39
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Dutch investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 November 2026. https://priyalifescience.com/clinical-trials-netherlands/condition/heart-failure

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Netherlands and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,171 studies in total at the last sync on 10 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 39 of those studies listing the condition Heart Failure.

How many Heart Failure trials are recruiting in Netherlands?

18 of the 39 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:17 UTC sync. A further 6 have not yet opened recruitment, 14 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Heart Failure), 39 studies
PhaseStudiesRecruitingShare
Not applicable18346.2%
Observational10625.6%
Phase 36515.4%
Phase 2225.1%
Phase 1112.6%
Phase 2/3112.6%
Phase 4102.6%

Most active sponsors

Lead sponsors with the most studies (Heart Failure)
Lead sponsorStudiesRecruiting
University Medical Center Groningen52
Medisch Spectrum Twente30
Boehringer Ingelheim22
Novo Nordisk A/S22
Abbott Medical Devices11
Ancora Heart, Inc.10
AstraZeneca11
Boston Scientific Corporation10
Corvia Medical10
EBR Systems, Inc.10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.